RxDoctor Payments Data

Joseph Cookman, DO

Interventional Cardiology · Fort Dodge, IANPI 1376525535

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $341 and has fallen 85.9% since, to $48 in 2025. That places this record below the midpoint for interventional cardiology clinicians in IA, where the typical reported total is $3,872.

$1,233in general payments, 2019–2025

Across 39 payments — averaging $31.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Shockwave Medical, Inc$251
  • Medtronic$179
  • Inari Medical, Inc.$143
  • Penumbra, Inc.$140
  • Abiomed$132
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$87
  • plus $301 from 9 others

What the payments were for

  • Food & beverage$1,233100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,233 in reported general payments places this provider in the 20th percentile of 64 interventional cardiology providers in Iowa.

See all interventional cardiology providers in Iowa

Medicare billing

Part B allowed, 2024
$79,416
Medicare patients
309
Services billed
637

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban29$15,626
Metoprolol Succinate14$189
Carvedilol19$97
Metoprolol Tartrate13$20
Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide13$8

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Fort Dodge

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →